ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New blood pressure combo aims to beat standard pill in major trial
Disease control Recruiting nowThis phase 3 trial tests whether a new combination drug (CKD-202A, containing sacubitril and valsartan) is better than the standard drug valsartan alone at lowering blood pressure in adults with essential hypertension. About 324 participants will receive either the new combo or t…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Hunt for childhood high blood pressure genes begins
Knowledge-focused Recruiting nowThis study aims to find the genes that cause high blood pressure in children and teens. Researchers will collect blood, urine, and other samples from 2300 people with or without the condition over up to 10 years. No treatments are tested; the goal is to understand the genetic cau…
Matched conditions: ESSENTIAL HYPERTENSION
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:44 UTC
-
New hypertension drug candidate BCD101 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called BCD101 in 56 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure drug levels in the blood. This tri…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Bichedam Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC